Pregnancy and Fertility-related Adverse Outcomes Associated with Infection: a Global Systematic Review and Meta-analysis

Overview

Journal Sex Transm Infect

Specialty Infectious Diseases

Date 2019 Dec 15

PMID 31836678

Citations 46

Authors

Weiming Tang

Jessica Mao

Katherine T Li

Jennifer S Walker

Roger Chou

Rong Fu

Weiying Chen

Toni Darville

Jeffrey Klausner

Joseph D Tucker

Affiliations

Soon will be listed here.

Abstract

Background: Genital chlamydia infection in women is often asymptomatic, but may result in adverse outcomes before and during pregnancy. The purpose of this study was to examine the strength of the relationships between chlamydia infection and different reproductive health outcomes and to assess the certainty of the evidence.

Methods: This review was registered and followed the Cochrane guidelines. We searched three databases to quantitatively examine adverse outcomes associated with chlamydia infection. We included pregnancy and fertility-related outcomes. We performed meta-analyses on different study designs for various adverse outcomes using unadjusted and adjusted analyses.

Results: We identified 4730 unique citations and included 107 studies reporting 12 pregnancy and fertility-related outcomes. Sixty-eight studies were conducted in high-income countries, 37 studies were conducted in low-income or middle-income countries, and 2 studies were conducted in both high-income and low-income countries. Chlamydia infection was positively associated with almost all of the 12 included pregnancy and fertility-related adverse outcomes in unadjusted analyses, including stillbirth (OR=5.05, 95% CI 2.95 to 8.65 for case-control studies and risk ratio=1.28, 95% CI 1.09 to 1.51 for cohort studies) and spontaneous abortion (OR=1.30, 95% CI 1.14 to 1.49 for case-control studies and risk ratio=1.47, 95% CI 1.16 to 1.85 for cohort studies). However, there were biases in the design and conduct of individual studies, affecting the certainty of the overall body of evidence. The risk of adverse outcomes associated with chlamydia is higher in low-income and middle-income countries compared with high-income countries.

Conclusion: Chlamydia is associated with an increased risk of several pregnancy and fertility-related adverse outcomes in unadjusted analyses, especially in low-income and middle-income countries. Further research on how to prevent the sequelae of chlamydia in pregnant women is needed.

Trial Registration Number: CRD42017056818.

Citing Articles

Uterine Microbiota and Bisphenols: Novel Influencers in Reproductive Health.

Castellanos-Ruiz D, Ojeda-Borbolla J, Ruiz-Garcia O, Pena-Corona S, Martinez-Pena A, Ibarra-Rubio M J Xenobiot. 2025; 15(1).

PMID: 39997369 PMC: 11856463. DOI: 10.3390/jox15010026.

Chronic Endometritis and Antimicrobial Resistance: Towards a Multidrug-Resistant Endometritis? An Expert Opinion.

Di Gennaro F, Guido G, Frallonardo L, Pennazzi L, Bevilacqua M, Locantore P Microorganisms. 2025; 13(1).

PMID: 39858965 PMC: 11767291. DOI: 10.3390/microorganisms13010197.

The global prevalence of Chlamydia trachomatis genital infection in pregnant women: a meta-analysis.

Salari N, Olfat N, Ghasemi H, Larti M, Beiromvand M, Mohammadi M Arch Gynecol Obstet. 2025; 311(2):529-542.

PMID: 39821423 PMC: 11890251. DOI: 10.1007/s00404-024-07928-x.

CT584 Is Not a Protective Vaccine Antigen against Respiratory Chlamydial Challenge in Mice.

Hoang-Phou S, Pal S, Slepenkin A, Abisoye-Ogunniyun A, Zhang Y, Gilmore S Vaccines (Basel). 2024; 12(10).

PMID: 39460301 PMC: 11512284. DOI: 10.3390/vaccines12101134.

Prevalence of bacterial vaginosis, sexually transmitted infections and their association with HPV infections in asymptomatic women attending antenatal care in Ethiopia.

Klein J, Runge I, Pannen A, Wakuma T, Abera S, Adissie A Ecancermedicalscience. 2024; 18:1783.

PMID: 39430093 PMC: 11489113. DOI: 10.3332/ecancer.2024.1783.

References

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Gencay M, Koskiniemi M, Ammala P, Fellman V, Narvanen A, Wahlstrom T . Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery. APMIS. 2000; 108(9):584-8. DOI: 10.1034/j.1600-0463.2000.d01-101.x. View

Malik A, Jain S, Rizvi M, Shukla I, Hakim S . Chlamydia trachomatis infection in women with secondary infertility. Fertil Steril. 2008; 91(1):91-5. DOI: 10.1016/j.fertnstert.2007.05.070. View

Liu B, Roberts C, Clarke M, Jorm L, Hunt J, Ward J . Chlamydia and gonorrhoea infections and the risk of adverse obstetric outcomes: a retrospective cohort study. Sex Transm Infect. 2013; 89(8):672-8. DOI: 10.1136/sextrans-2013-051118. View

Low N, Bender N, Nartey L, Shang A, Stephenson J . Effectiveness of chlamydia screening: systematic review. Int J Epidemiol. 2008; 38(2):435-48. DOI: 10.1093/ije/dyn222. View

Siemer J, Theile O, Larbi Y, Fasching P, Danso K, Kreienberg R . Chlamydia trachomatis infection as a risk factor for infertility among women in Ghana, West Africa. Am J Trop Med Hyg. 2008; 78(2):323-7. View

Bebear C, De Barbeyrac B . Genital Chlamydia trachomatis infections. Clin Microbiol Infect. 2009; 15(1):4-10. DOI: 10.1111/j.1469-0691.2008.02647.x. View

Fleiss J . The statistical basis of meta-analysis. Stat Methods Med Res. 1993; 2(2):121-45. DOI: 10.1177/096228029300200202. View

Joseph Davey D, Shull H, Billings J, Wang D, Adachi K, Klausner J . Prevalence of Curable Sexually Transmitted Infections in Pregnant Women in Low- and Middle-Income Countries From 2010 to 2015: A Systematic Review. Sex Transm Dis. 2016; 43(7):450-8. PMC: 5889114. DOI: 10.1097/OLQ.0000000000000460. View

10.

Blas M, Canchihuaman F, Alva I, Hawes S . Pregnancy outcomes in women infected with Chlamydia trachomatis: a population-based cohort study in Washington State. Sex Transm Infect. 2007; 83(4):314-8. PMC: 2598687. DOI: 10.1136/sti.2006.022665. View

11.

Ong J, Chen M, Hocking J, Fairley C, Carter R, Bulfone L . Chlamydia screening for pregnant women aged 16-25 years attending an antenatal service: a cost-effectiveness study. BJOG. 2015; 123(7):1194-202. DOI: 10.1111/1471-0528.13567. View

12.

Howie S, Horner P, Horne A . Chlamydia trachomatis infection during pregnancy: known unknowns. Discov Med. 2011; 12(62):57-64. View

13.

Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

14.

Sweet R, Landers D, Walker C, Schachter J . Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol. 1987; 156(4):824-33. DOI: 10.1016/0002-9378(87)90338-3. View

15.

Salmani M, Mindolli P, Vishwanath G . Seroprevalence of Chlamydia trachomatis infection in women with bad obstetric history and infertility. J Commun Dis. 2013; 43(4):243-7. View

16.

Osser S, Persson K, Liedholm P . Tubal infertility and silent chlamydial salpingitis. Hum Reprod. 1989; 4(3):280-4. DOI: 10.1093/oxfordjournals.humrep.a136888. View

17.

van de Laar M, Fontaine J . ECDC guidance on chlamydia control in Europe: next steps. Euro Surveill. 2009; 14(26). View

18.

Idahl A, Jurstrand M, Olofsson J, Fredlund H . Mycoplasma genitalium serum antibodies in infertile couples and fertile women. Sex Transm Infect. 2015; 91(8):589-91. DOI: 10.1136/sextrans-2015-052011. View

19.

Garland S, Lees M, Skurrie I . Chlamydia trachomatis--role in tubal infertility. Aust N Z J Obstet Gynaecol. 1990; 30(1):83-6. DOI: 10.1111/j.1479-828x.1990.tb03205.x. View

20.

QUINN P, Petric M, BARKIN M, Butany J, Derzko C, Gysler M . Prevalence of antibody to Chlamydia trachomatis in spontaneous abortion and infertility. Am J Obstet Gynecol. 1987; 156(2):291-6. DOI: 10.1016/0002-9378(87)90270-5. View